Panion & BF Biotech Inc values innovation, scientific excellence, and a commitment to improving human and animal health. The company is a biotechnology firm specializing in the development and commercialization of novel therapeutics for various diseases. Panion & BF Biotech Inc follows a corporate philosophy centered around research-driven approaches, collaboration with global partners, and ethical business practices. With a strong emphasis on advancing healthcare and addressing unmet medical needs, Panion & BF Biotech Inc strives to create value for patients, shareholders, and the broader society.

Panion & BF Biotech Inc is primarily present in Taiwan.

Panion & BF Biotech Inc. has achieved several significant milestones in its journey. One of the notable accomplishments includes the successful development and commercialization of innovative biotechnological products. The company has also established strong strategic partnerships with renowned pharmaceutical companies and research institutions. Moreover, Panion & BF Biotech Inc. has demonstrated consistent growth in its market presence and financial performance, which has garnered recognition from industry experts and investors. These achievements highlight the company's commitment to excellence and reinforce its position as a leading player in the biotech sector. Panion & BF Biotech Inc.'s dedication to innovation and strategic collaborations has enabled it to make remarkable strides in advancing healthcare solutions.

Panion & BF Biotech Inc is a pharmaceutical company that specializes in the development and production of animal health products. Founded in 2008, the company is based in Taiwan and has gained recognition worldwide for its expertise in the field of biotechnology. Panion & BF Biotech Inc has a strong commitment to research and innovation, continually seeking new solutions to improve animal health and welfare. With a dedicated team of professionals, the company has built a solid reputation for delivering high-quality products that meet the needs of both animals and their owners. Today, Panion & BF Biotech Inc continues to be a leading player in the animal health industry, making significant contributions to veterinary care.

Some of the main competitors of Panion & BF Biotech Inc in the market include company A, company B, and company C. These competitors also operate in the same industry and offer similar products and services as Panion & BF Biotech Inc. However, Panion & BF Biotech Inc distinguishes itself through its innovative research and development, strong market presence, and high-quality products. As a leading player in the industry, Panion & BF Biotech Inc competes effectively by continuously improving its offerings and maintaining a strong customer base.

Panion & BF Biotech Inc is primarily active in the biotechnology industry.

The business model of Panion & BF Biotech Inc is focused on developing and commercializing innovative solutions in the field of biotechnology. They primarily specialize in the research, development, and production of animal health products, specifically for livestock. Panion & BF Biotech Inc strives to improve animal health and contribute to the overall sustainability of the agricultural industry. They aim to provide effective and safe solutions to prevent and treat various animal diseases, ensuring the well-being and productivity of livestock. With a strong commitment to innovation and research, Panion & BF Biotech Inc continues to drive advancements in the biotechnology sector.

P/E odnos Panion & BF Biotech iznosi 59,04.

KUV kompanije Panion & BF Biotech iznosi 3,96.

AlleAktien kvalitativni skor za Panion & BF Biotech je 7/10.

očekivana Panion & BF Biotech promet je 2,09 milijardi TWD.

Dobit očekivana Panion & BF Biotech je 139,93 mil. TWD.

The company Panion & BF Biotech Inc is a biopharmaceutical company based in Denmark and Taiwan. The company's business model is based on the development and marketing of biotechnological products for animal health. The company focuses on the areas of neuropathic pain in dogs and replacement therapy for diabetic animals.

Panion & BF Biotech isplaćuje dividendu od 1,50 TWD raspoređenu preko isplata u toku godine.

Dividenda za Panion & BF Biotech trenutno ne može biti izračunata ili kompanija ne isplaćuje dividendu.

ISIN od Panion & BF Biotech je TW0001760007.

Oznaka za praćenje akcija kompanije Panion & BF Biotech je 1760.TW.

U poslednjih 12 meseci, Panion & BF Biotech je isplatio dividendu u iznosu od 2,00 TWD . To odgovara dividendnom prinosu od oko 2,08 %. Za narednih 12 meseci, Panion & BF Biotech će verovatno isplatiti dividendu od 2,00 TWD.

Dividendski prinos od Panion & BF Biotech trenutno iznosi 2,08 %.

Panion & BF Biotech isplaćuje dividende na kvartalnom nivou. One se isplaćuju u mesecima јул, јул, август, јул.

Panion & BF Biotech je isplaćivao dividendu svake godine u poslednjih 10 godina.

Za narednih 12 meseci očekuju se dividende u iznosu od 2,00 TWD. To odgovara dividendnom prinosu od 2,13 %.

Panion & BF Biotech se svrstava u sektor 'Zdravlje'.

Da biste primili poslednju dividendu od Panion & BF Biotech od 10. 7. 2024. u iznosu od 1,5 TWD, morali ste da imate akciju u depou pre Ex-dana 13. 6. 2024..

Isplata poslednje dividende izvršena je 10. 7. 2024..

U godini 2023 kompanija Panion & BF Biotech je isplatila 1,5 TWD kao dividende.

Dividende od Panion & BF Biotech se isplaćuju u TWD.